Targeting notch signaling in pancreatic cancer

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 5, 2010, Pages 541-552

  Ristorcelli, Elodie ^a   Lombardo, Dominique ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cancer; Notch; Pancreas; Signalling

Indexed keywords

ALPHA SECRETASE; CETUXIMAB; FLUOROURACIL; GEMCITABINE; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL TRIAL; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; HUMAN; NONHUMAN; ORGANOGENESIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; RECEPTOR DOWN REGULATION; REVIEW;

HUMANS; ONCOGENES; PANCREATIC NEOPLASMS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 77951096677     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728221003769895     Document Type: Review

References (99)

1. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321:1801-1806
2. Apelqvist A, Li H, Sommer L, et al. Notch signaling controls pancreatic cell differentiation. Nature 1999;400:877-881
3. Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006;107:2223-2233
4. Sj€olund J, Manetopoulos C, Stockhausen MT, et al. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer 2005;41:2620-2629
5. Wang Z, Zhang Y, Li Y, et al. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006;5:483-493
6. Ringel J, Jesnowski R, Moniaux N, et al. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Res 2006;66:9045-9053
7. Ristorcelli E, Beraud E, Mathieu S, et al. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles. Int J Cancer 2009;125:1016-1026
8. Miyamoto Y, Maitra A, Ghosh B, et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003;3:565-576
9. Jensen J, Heller RS, Funder-Nielsen T, et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 2000;49:163-176
10. Wang Z, Zhang Y, Banerjee S, et al. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006;106:2503-2513
11. Plentz R, Park JS, Rhim AD, et al. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterol 2009;136:1741-1749
12. Kadesch T. Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev 2004;14:506-512
13. Choi K, Ahn YH, Gibbons DL, et al. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. J Biol Chem 2009;284:17766-17774
14. Tien AC, Rajan A, Bellen HJ. A Notch updated. J Cell Biol 2009;184:621-629
15. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007;98:621-628
16. Postina R. A closer look at alpha-secretase. Curr Alzheimer Res 2008;5:179-186
17. Brou C, Logeat F, Gupta N, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 2000;5:207-216
18. Matthews V, Schuster B, Schütze S, et al. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 2003;278:38829-38839
19. Kimberly WT, LaVoie MJ, Ostaszewski BL, et al. Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. J Biol Chem 2002;277:35113-35117
20. Kim SK, Park HJ, Hong HS, et al. ERK1/2 is an endogenous negative regulator of the gamma-secretase activity. FASEB J 2006;20:157-159
21. Kimberly WT, LaVoie MJ, Ostaszewski BL, et al. gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 2003;100:6382-6387
22. Okochi M, Steiner H, Fukumori A, et al. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J 2002;21:5408-5416
23. Gupta-Rossi N, Six E, LeBail O, et al. Monoubiquitination and endocytosis direct gamma-secretase cleavage of activated Notch receptor. J Cell Biol 2004;166:73-83
24. Katho M, Katho M. Notch signaling in gastrointestinal tract. Int J Oncol 2007;30:247-251
25. Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003;194:237-255
26. Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007;17:52-59
27. Moloney DJ, Panin VM, Johnston SH, et al. Fringe is a glycosyltransferase that modifies Notch. Nature 2000;406:369-375
28. Golson ML, Le Lay J, Gao N, et al. Jagged1 is a competitive inhibitor of Notch signaling in the embryonic pancreas. Mech Dev 2009;126:687-699
29. Xu A, Lei L, Irvine KD. Regions of drosophila notch that contribute to ligand binding and the modulatory influence of Fringe. J Biol Chem 2005;280:30158-30165
30. Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003;12(1):R9-13
31. Vaccari T, Lu H, Kanwar R, et al. Endosomal entry regulates Notch receptor activation in Drosophila melanogaster. J Cell Biol 2008;180:755-762
32. McGill MA, Dho SE, Weinmaster G, et al. Numb regulates post-endocytic trafficking and degradation of Notch-1. J Biol Chem 2009;284:26427-26438
33. Shaye DD, Greenwald I. Endocytosis-mediated downregulation of LIN-12/Notch upon Ras activation in Caenorhabditis elegans. Nature 2002;420:686-690
34. Osenkowski P, Ye W, Wang R, et al. Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem 2008;283:22529-22540
35. Müller P, Crofts JD, Newman BS, et al. SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res Treat 2009: Published online 26 March 2009, doi: 10.1007/s10549-009-0381-6
36. Hartman J, Müller P, Foster JS, et al. HES-1 inhibits 17beta-estradiol and heregulin-beta1-mediated upregulation of E2F-1. Oncogene 2004;23:8826-8833
37. Weng AP, Aster JC. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev 2004;14:48-54
38. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776
39. Lammert E, Brown J, Melton DA. Notch gene expression during pancreatic organogenesis. Mech Dev 2000;94:199-203
40. Beres TM, Masui T, Swift GH, et al. PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L. Mol Cell Biol 2006;26:117-130
41. Nakhai H, Siveke JT, Klein B, et al. Conditional ablation of Notch signaling in pancreatic development. Development 2008;135:2757-2765
42. Kim W, Shin YK, Kim BJ, Egan JM. Notch signaling in pancreatic endocrine cell and diabetes. Biochem Biophys Res Commun 2010;392:247-251
43. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037
44. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev 2001;15:111-127
45. Jensen J. Gene regulatory factors in pancreatic development. DevDyn 2004;229:176-200
46. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005;146:1025-1034
47. Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 2003;3:756-767
48. Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH-1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-271
49. Sj€olund J, Manetopoulos C, Stockhausen MT, et al. The Notch pathway in cancer: differentiation gone awry. Eur J Cancer 2005;41:2620-2629
50. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586
51. Doucas H, Mann CD, Sutton CD, et al. Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt. J Surg Oncol 2008;97:63-68
52. Eastham AM, Spencer H, Soncin F, et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007;67:11254-11262
53. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005;132:3151-3161
54. von Burstin J, Eser S, Paul MC, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/ HDAC2 repressor complex. Gastroenterology 2009;137:361-371
55. Sahlgren C, Gustafsson MV, Jin S, et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008;105:6392-6397
56. Wang Z, Li Y, Kong D, et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 2009;69:2400-2407
57. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, et al. Molecular pathology of pancreatic cancer. Cancer J 2001;7:251-258
58. De La O JP, Murtaugh LC. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling. Cell Cycle 2009;8:1860-1864
59. De La O JP, Emerson LL, Goodman JL, et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci USA 2008;105:18907-18912
60. Gansauge S, Gansauge F, Ramadani M, et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997;57:1634-1637
61. D'Souza B, Miyamoto A, Weinmaster G. The many facets of Notch ligands. Oncogene 2008;27:5148-5167
62. Fre S, Pallavi SK, Huyghe M, et al. Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci USA 2009;106:6309-6314
63. Fitzgerald K, Harrington A, Leder P. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 2000;19:4191-4198
64. Morrow D, Cullen JP, Liu W, et al. Sonic Hedgehog induces Notch target gene expression in vascular smooth muscle cells via VEGF-A. Arterioscler Thromb Vasc Biol 2009;29:1112-1118
65. Blokzijl A, Dahlqvist C, Reissmann E, et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 2003;163:723-728
66. Morton JP, Lewis BC. Shh signaling and pancreatic cancer: implications for therapy? Cell Cycle 2007;6:1553-1557
67. Pasca di Magliano M, Biankin AV, Heiser PW, et al. Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS One 2007;2:e1155
68. Simeone DM, Pham T, Logsdon CD. Disruption of TGFbeta signaling pathways in human pancreatic cancer cells. Ann Surg 2000;232:73-80
69. Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002;8:979-986
70. Chen Y, Fischer WH, Gill GN. Regulation of the ERBB-2 promoter by RBPJk and NOTCH. J Biol Chem 1997;272:14110-14114
71. Sarkar FH, Banerjee S, Li Y. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol Appl Pharmacol 2007;224:326-336
72. Shin HM, Minter LM, Cho OH, et al. Notch-1 augments NF-kB activity by facilitating its nuclear retention. EMBO J 2006;25:129-138
73. Sun Y, Lowther W, Kato K, et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 2005;24:5365-5374
74. Soares R, Balogh G, Guo S, et al. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 2004;18:2333-2343
75. J€ogi A, Øra I, Nilsson H, et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-7026
76. Palomero T, Sulis ML, Cortina M, et al. Mutational loss of PTEN induces resistance to NOTCH-1 inhibition in T-cell leukemia. Nat Med 2007;13:1203-1210
77. Lee MH, Koria P, Qu J, et al. JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J 2009;23:3874-3883
78. Tian H, Callahan CA, DuPree KJ, et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 2009;106:4254-4259
79. Ingram WJ, McCue KI, Tran TH, et al. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signaling. Oncogene 2008;27:1489-1500
80. Jemal A, Seigel R, Ward E, et al. Cancer statistics. Cancer J Clin 2007;57:43-66
81. Mancuso A, Calabrò F, Sternberg CN. Current therapies and advances in the treatment of pancreatic cancer. Crit Rev Oncol Hematol 2006;58:231-241
82. Borja-Cacho D, Jensen EH, Saluja AK, et al. Molecular targeted therapies for pancreatic cancer. Am J Surg 2008;196:430-441
83. Pliarchopoulou K, Pectasides D. Pancreatic cancer: current and future treatment strategies. Cancer Treat Rev 2009;35:431-436
84. Novarino I, Chiappin GF, Bertelli A, et al. Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer. Ann Oncol 2004;15:474-477
85. Laheru D, Jaffee EM. Immunotherapy for pancreatic cancer -- science driving clinical progress. Nat Rev Cancer 2005;5:459-467
86. Cartwright T, Richards DA, Boehm KA. Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network. Cancer Control 2008;15:308-313
87. Seymour PA, Freude KK, Tran MN, et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci USA 2007;104:1865-1870
88. De La O JP, Murtaugh LC. Notch signaling: where pancreatic cancer and differentiation meet? Gastroenterol 2009;136:1499-1502
89. Aiello A, Pandini G, Frasca F, et al. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology 2006;147:4463-4475
90. Li K, Li Y, Wu W, et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem 2008;283:8046-8054
91. Shih IeM, Wang TL. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 2007;67:1879-1882
92. Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006;66:1517-1525
93. Paris D, Quadros A, Patel N, et al. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur J Pharmacol 2005;514:1-15
94. Aleksic T, Feller SM. Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun Signal 2008;6:8-20
95. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.Proc Natl Acad Sci USA 2007;104:5103-5108
96. Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009;324:1457-1461
97. Mori T, Doi R, Koizumi M, et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 2004;3:29-37
98. Luo Y, Cai J, Xue H, et al. SDF1alpha/ CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 2006;398:291-295
99. Benkoël L, Bernard JP, Payan-Defais MJ, et al. Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues. Mol Cancer Ther 2009;8:282-291